Table 2.
Type of Study | Patients and Time | Comparing Diets | Results | Possible Bias |
---|---|---|---|---|
Prospective randomized controlled trial (Milovanova LY et al., 2023) [113] |
85 CKD 3b-4 stages (12 months) | Soy LPD + KA versus traditional LPD + KA | Soy LPD + KA showed:
|
|
Prospective randomized controlled clinical study (Feiten SF et al., 2005) [114] |
24 patients eGFR < 25 mL/min (4 months) |
VLPDs versus conventional LPD |
|
|
Prospective multicentre randomized controlled study (Brunori G. et al., 2007) [115] |
56 uremic non-diabetic patients older than 70 years with eGFR of 5 to 7 mL/min (median follow-up was 26.5 months) |
VLPDs versus dialysis |
|
|
Prospective randomized crossover-controlled trial (Di Iorio BR et al., 2018) [116] |
60 patients on CKD stage 3b-4 (18 months) |
Free diet (FD), Mediterranean diet (MD), and VLPDs | MD and VLPDs versus FD showed:
|
|
Prospective randomized controlled trial (Garneata L et al., 2016) [117] |
207 non-diabetic adults with stable eGFR < 30 mL/min (18 months) |
VLPDs versus conventional LPD | Patients on a VLPDs showed:
|
|
Prospective randomized controlled trial (Bellizzi V et al., 2022) [119] |
233 patients (diabetics included) with CKD stage 4 or 5 (36 months) |
VLPDs versus conventional LPD | VLPDs resulted in safe nutrition but without any benefit with regard to renal survival and metabolic parameters. | Low adherence to diet (only 3 patients followed the prescribed 0.3 g/kg/day of protein intake) |
LPD + KA: Low Protein Diet plus Keto Analogues. eGFR: estimated Glomerular Filtration Rate. LPD: Low Protein Diet. VLPDs: Very Low Protein Diet supplemented.